Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Genzyme Gets Mixed Results On Renvela Powder Formulation

Related Content

Amgen Gains Phase II Phosphate Binder With Acquisition of Ilypsa

Jun 05 2007

Genzyme Optimistic About Renagel’s Future Despite Fresenius’ Deal For PhosLo

Oct 16 2006

Genzyme Will Look To Differentiate Renvela With Improved Dosing

Dec 21 2006

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window